Book orders can be placed by telephone or via the website. For regional distributors or to order via the website, please go to: www.fastfacts.com For telephone orders, please call 01752 202301 (UK), +44 1752 202301 (Europe), 1 800 247 6553 (USA, toll free) or +1 419 281 1802 (Americas).
Fast Facts is a trademark of Health Press Limited.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the express permission of the publisher.
The rights of Anne Edwards, Jackie Sherrard and Jonathan Zenilman to be identified as the authors of this work have been asserted in accordance with the Copyright, Designs & Patents Act 1988 Sections 77 and 78.
The publisher and the authors have made every effort to ensure the accuracy of this book, but cannot accept responsibility for any errors or omissions.
For all drugs, please consult the product labeling approved in your country for prescribing information.
Introduction 5
Glossary of abbreviations 4
Approach to the patient 12
Urethritis 26
Vaginal discharge 33
Genital dermatoses, vulvitis and balanitis 41
Genital ulcer disease 47
Pelvic inflammatory disease and epididymo-orchitis 51
Genital pain syndromes 59
Bacterial infections 62
Herpes simplex, human papillomavirus infections and molluscum contagiosum 92 
Introduction
Sexually transmitted infections (STIs), particularly human immunodeficiency virus (HIV) infection, are an important cause of morbidity and mortality worldwide, and are responsible for the loss of many productive years. They have a disproportionate impact on adolescents and young adults. In developed countries, the incidence of most viral and bacterial STIs is increasing. The World Health Organization estimated that in 1999 there were 340 million cases of selected curable STIs (gonorrhea, Chlamydia infection, syphilis, chancroid and trichomoniasis), 90% occurring in resource-poor countries. Among the sexually active population, the prevalence of herpes simplex type 2 infection and of sexually transmitted human papillomavirus infection is estimated to be 20-40% and 30-60%, respectively. These rates are higher in developing countries. Since 1998 there has been an upsurge of STIs in homosexual men, a trend that has profound implications for the epidemiology of STIs and HIV infection.
The annual cost of STIs is estimated at US$7.18 billion in the USA, and that of treating the short-term effects of STIs at £700 million in the UK. Two STIs -gonorrhea and chancroid -no longer respond reliably to readily available and inexpensive antimicrobials and, increasingly, expensive third-generation cephalosporins and fluoroquinolones are required to treat these two diseases, causing particular problems in resource-poor areas.
STIs are important cofactors in the sexual transmission of HIV. In addition, the treatment of a number of STIs has become more challenging in immunocompromised individuals with HIV infection. Every family physician now encounters patients with STIs. We hope that Fast Facts: Sexually Transmitted Infections will provide a useful summary of current thinking on the diagnosis and effective management of these wide-ranging infections.
Treatment guidelines
The treatment guidelines presented in each chapter are adapted from the UK guidelines for the management of STIs. The US recommendations (2006) 
Sexually transmitted pathogens
*Bacterial vaginosis is seen almost exclusively in women who have been sexually active but the relevance of sexual transmission is not clear.
Viral pathogens
• Herpes simplex virus (genital herpes): HSV 1 and HSV 2
• Human immunodeficiency virus (HIV)
• Human papillomavirus (genital warts)
• Hepatitis B virus
• Human herpesvirus-8 (Kaposi's sarcoma)
• Human T-cell lymphotropic viruses: types 1 and 2 (HTLV1 & 2)
• Cytomegalovirus
• Hepatitis C virus -sexual transmission occurs occasionally (< 5% cases)
• Molluscum contagiosumcaused by a member of the Poxviridae family
Ectoparasites
(transmission occurs through close contact, sexual intercourse is not required)
• Phthirus pubis (pubic lice)
• Sarcoptes scabiei (scabies)
Bacterial pathogens
• Chlamydia trachomatis
• Neisseria gonorrhoeae (gonorrhea)
• Treponema pallidum (syphilis)
• Genital mycoplasmas (including Mycoplasma genitalium)
• Haemophilus ducreyi (chancroid)
• Klebsiella granulomatis (donovanosis) Vaginal discharge is common and is often not pathological. Normal discharge ranges in appearance from mucoid to opaque, and in quantity from minimal to copious, and the quality and quantity of discharge may vary over the menstrual cycle and over a woman's lifetime. Most women are aware of a change from their normal pattern; it is therefore not surprising that a spontaneous complaint of abnormal vaginal discharge has good positive predictive value for the detection of pathology. Leading questions and the investigation of asymptomatic discharge are less helpful and may result in asymptomatic women becoming concerned.
Associated vulvovaginal symptoms may provide clues to the etiology. For example, in some women an underlying vulval disorder may be relevant; a careful history and examination should distinguish this patient group (see Chapter 5).
Recent studies have confirmed that most infectious discharge is caused by vaginal pathogens (Table 4 .1). Purely cervical infections (e.g. gonorrhea or chlamydial infection) are rarely responsible for vaginal discharge, which, in this setting, is usually due to concomitant vaginal infection, such as bacterial vaginosis (Figure 4 .1) or Candida vulvovaginitis (Figure 4 .2). Women may not appreciate this difference between vaginal and cervical infection, and the cause of discharge needs to be resolved by physical examination.
Assessment and investigation
A history and examination should be undertaken (see Chapter 2). The assessment should routinely include a drug history (with particular emphasis on antibiotic use), and any associated vulvovaginal symptoms should be noted (Table 4 .2). Women with poorly controlled diabetes may present with troublesome vulvovaginal candidiasis. The vulval skin should be inspected carefully to exclude any underlying dermatoses (see Chapter 5). If vaginal discharge is observed during an examination, it is important to establish whether the discharge is usual for the 
